GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients.

Lihua YuLulu HuangDanna LinXiaorong LaiLi WuXu LiaoJiale LiuYinghua ZengLichan LiangGuanmei ZhangBin WangZhu WuShaohua TaoYuchen LiuCheng JiaoLung-Ji Chang Li-Hua Yang

Published in: Journal of cancer research and clinical oncology (2021)

The 4SCAR-GD2 T-cell therapy demonstrated antitumor effect and manageable toxicities, indicating its potential to benefit children with refractory and/or recurrent NB.

Keyphrases

young adults
replacement therapy
wound healing
smoking cessation